Assura Group has published its full year figures for the period ended 31 March 2014. Over the year the EPRA NAV rose by 12.4% to 43.4p. The quarterly dividend is 0.45p per share (49% higher than the previous year). Assura Group bought 32 GP surgeries in September 2013 and completed eight new projects during the period and, at the year end, had five projects under construction and had identified another 28 potential schemes (though they say they are frustrated by NHS delays in approving projects). The eight completed projects generate an initial yield of 6.7%.
They have secured additional funding with a new £30m facility supplied by RBS and Barclays at a cost of 185 basis points over LIBOR.